Limba, John Michael A.

HRN: 01-62-25  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/01/2024
04/08/2024
IVT
300mg
Q8
Supraclavicular Abscess, Right
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: